Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Juvenile Idiopathic Arthritis”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Testing effectiveness (Phase 2)Study completedNCT00426218
What this trial is testing

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Arthritis, Juvenile Rheumatoid
Novartis 26
Post-approval studies (Phase 4)Study completedNCT03301883
What this trial is testing

Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 62
Not applicableLooking for participantsNCT07000916
What this trial is testing

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Who this might be right for
Juvenile Idiopathic ArthritisRheumatoid ArthritisPsoriatic Arthritis+3 more
Université Catholique de Louvain 1,000
Not applicableUnknownNCT00006055
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

Who this might be right for
Purpura, Schoenlein-HenochGraft Versus Host DiseaseAnemia, Hemolytic, Autoimmune+11 more
Fairview University Medical Center 10
Large-scale testing (Phase 3)Ended earlyNCT00174291
What this trial is testing

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

Who this might be right for
Endocrine System Diseases
Pfizer 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07625384
What this trial is testing

Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease

Who this might be right for
Still Disease
R-Pharm International, LLC 52
Early research (Phase 1)Study completedNCT00010335
What this trial is testing

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Who this might be right for
Systemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more
Fred Hutchinson Cancer Center 6
Not applicableNot Yet RecruitingNCT07737470
What this trial is testing

Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research

Who this might be right for
PericarditisTako-TSUBO CardiomyopathyMyocarditis+12 more
Assistance Publique - Hôpitaux de Paris 300
Not applicableStudy completedNCT01697254
What this trial is testing

The CARRA Registry

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusMixed Connective Tissue Disease+9 more
Duke University 9,587
Post-approval studies (Phase 4)Study completedNCT00815282
What this trial is testing

Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusJuvenile Dermatomyositis
N.M. Wulffraat 135
Testing effectiveness (Phase 2)Study completedNCT00570661
What this trial is testing

Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis

Who this might be right for
Active SystemicOnset Juvenile Idiopathic Arthritis
Italfarmaco 17
Not applicableNot Yet RecruitingNCT06718049
What this trial is testing

Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 9
Not applicableStudy completedNCT02453880
What this trial is testing

Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness

Who this might be right for
DepressionAnxietyInflammatory Bowel Disease+2 more
Stanford University 14
Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Not applicableLooking for participantsNCT04833465
What this trial is testing

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusFibromyalgia
Children's National Research Institute 90
Not applicableLooking for participantsNCT04402086
What this trial is testing

Rheumatology Patient Registry and Biorepository

Who this might be right for
Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more
Yale University 5,000
Large-scale testing (Phase 3)Ended earlyNCT00078806
What this trial is testing

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 19
Testing effectiveness (Phase 2)Ended earlyNCT01603355
What this trial is testing

Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis

Who this might be right for
Juvenile Idiopathic Arthritis Associated Uveitis
Eric B. Suhler 3
Large-scale testing (Phase 3)Study completedNCT00339157
What this trial is testing

Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Who this might be right for
Systemic-Onset Juvenile Idiopathic Arthritis
Institut National de la Santé Et de la Recherche Médicale, France 24
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Next Page